Page last updated: 2024-11-02

oxidopamine and Chorea Disorders

oxidopamine has been researched along with Chorea Disorders in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
"Chorea is a manifestation clearly related to increased dopaminergic (DA) activity."1.38Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity. ( Camargos, A; Cardoso, F; Carneiro, M; Chávez-Olórtegui, C; Cruz, L; Dias, F; Dias-Lopes, C; Doyle, F; Lopes, L; Mendes, M; Tavares, R, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doyle, F1
Cardoso, F1
Lopes, L1
Mendes, M1
Dias, F1
Cruz, L1
Tavares, R1
Camargos, A1
Carneiro, M1
Dias-Lopes, C1
Chávez-Olórtegui, C1

Other Studies

1 other study available for oxidopamine and Chorea Disorders

ArticleYear
Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity.
    Neuroscience letters, 2012, Aug-15, Volume: 523, Issue:2

    Topics: Adult; Animals; Autoantibodies; Child; Chorea; Corpus Striatum; Disease Models, Animal; Female; Huma

2012